Back to Journals » OncoTargets and Therapy » Volume 7

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Total article views   HTML views PDF downloads Totals
16,349 Dovepress* 12,839+ 3,437 16,276
PubMed Central* 3,510 1,168 4,678
Totals 16,349 4,605 20,954
*Since 5 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed and Google Scholar